Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Exosome Diagnostics boosts research and management team

This article was originally published in Clinica

Executive Summary

Exosome Diagnostics (New York, New York), a company focused on commercialising its proprietary genetics-based diagnostics for oncology and endocrinology, has appointed Johan Skog as director of genetics research; Wayne Comper as chief scientific officer; and Tom Tsakeris as director of regulatory affairs. Mr Skog discovered and invented Exosome’s blood-based diagnostics and in his new role will oversee the firm’s research programme. He will continue as a post-doctoral researcher at the molecular neurogenetics unit of Massachusetts General Hospital. Mr Comper joins from AusAm Biotechnologies; he has had more than 160 articles published in peer reviewed international journals. Mr Tsakeris joins from Devices and Diagnostics Consulting Group, where he was president. He has held management roles at the US FDA, including at the Office for Device Evaluation (director) and the Center for Devices and Radiological Health.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT042141

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel